q2 adjusted earnings per share $0.41.
q3 adjusted earnings per share $0.41.
q2 adjusted earnings per share $0.41.
q2 sales $464.4 million versus refinitiv ibes estimate of $458.2 million.
qtrly base business revenues increased 7% compared to 2019.
q2 sales $58.4 million versus refinitiv ibes estimate of $58 million.
q2 sales $40.9 million versus refinitiv ibes estimate of $41.8 million.
qtrly adjusted ebitda before covid-19 expenses as a percentage of net sales was 18.3%.
qtrly base business net sales increased 7.1 percent to $26.4 million.
qtrly net sales growth of nearly 40% versus prior year.
q2 adjusted ebitda before covid-19 expenses was $85 million, a decrease of $21.9 million, or 20.5%.
q2 sales fell 27.7 percent to $8.8 million.
compname reports q2 adjusted earnings per share $0.5.
q2 gross profit fell 26.2 percent to $134.1 million.
q2 sales $105.7 million versus refinitiv ibes estimate of $107.4 million.
compname reports fourth quarter 2021 results; announces 80% list price increases in approximately 80% of its portfolio.
